Hemodynamics, fluids & transfusion
Continuous Noninvasive Blood Pressure Measurement With “ClearSight” Compared to Standard Intermittent Blood Pressure Measurement in Patients With Peripheral Arterial Disease. Are Potential Differences Influenced by Phenylephrine or Dobutamine?
Primary result · Agreement cNIBP-CS vs iNIBP (Bland-Altman)Result — go to the resultMean bias 13 mmHgAuthors' conclusion
In this study, in patients with PAD, cNIBP-CS showed an underestimation of blood pressure compared to iNIBP in phenylephrine- and dobutamine-treated patients. Compared to previous studies, a larger bias and wider 95% LOA were found.
Study context
- Population
- Patients with peripheral arterial disease (PAD) undergoing percutaneous transluminal angioplasty of the lower limbs
- Participants
- 34 patients
- Comparison
- Continuous noninvasive BP vs standard intermittent noninvasive BP
- Primary endpoint
- Agreement between continuous noninvasive BP measurement with the ClearSight system (cNIBP-CS) and standard intermittent noninvasive BP measurement (iNIBP)
Methodological detailssingle-centre
- Single-centre
Primary result
Agreement cNIBP-CS vs iNIBP (Bland-Altman)
Mean bias
13 mmHg
As reported in the abstract
Further findings
Mean bias cNIBP-CS vs iNIBP by vasoactive medication (subgroup)
Mean bias cNIBP-CS vs iNIBP by vasoactive medication (subgroup)
- Similar mean bias for phenylephrine and dobutamine
Original publication
Continuous Noninvasive Blood Pressure Measurement With “ClearSight” Compared to Standard Intermittent Blood Pressure Measurement in Patients With Peripheral Arterial Disease. Are Potential Differences Influenced by Phenylephrine or Dobutamine? J Cardiothorac Vasc Anesth. Published 10 August 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →